CA2088273C - Procedes pour la formulation de composes a base de loperamide sous forme posologique orale solide - Google Patents

Procedes pour la formulation de composes a base de loperamide sous forme posologique orale solide

Info

Publication number
CA2088273C
CA2088273C CA002088273A CA2088273A CA2088273C CA 2088273 C CA2088273 C CA 2088273C CA 002088273 A CA002088273 A CA 002088273A CA 2088273 A CA2088273 A CA 2088273A CA 2088273 C CA2088273 C CA 2088273C
Authority
CA
Canada
Prior art keywords
loperamide
solid oral
dosage form
oral dosage
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002088273A
Other languages
English (en)
Other versions
CA2088273A1 (fr
Inventor
Daniel Louis Barone
Francis Bernard Chapura
Shawn Alan Denny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2088273A1 publication Critical patent/CA2088273A1/fr
Application granted granted Critical
Publication of CA2088273C publication Critical patent/CA2088273C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002088273A 1990-08-09 1991-07-29 Procedes pour la formulation de composes a base de loperamide sous forme posologique orale solide Expired - Fee Related CA2088273C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56501090A 1990-08-09 1990-08-09
US565,010 1990-08-09

Publications (2)

Publication Number Publication Date
CA2088273A1 CA2088273A1 (fr) 1992-02-10
CA2088273C true CA2088273C (fr) 1996-05-14

Family

ID=24256836

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002088273A Expired - Fee Related CA2088273C (fr) 1990-08-09 1991-07-29 Procedes pour la formulation de composes a base de loperamide sous forme posologique orale solide

Country Status (9)

Country Link
EP (1) EP0542879A1 (fr)
JP (1) JPH06500104A (fr)
AU (1) AU661972B2 (fr)
CA (1) CA2088273C (fr)
FI (1) FI930536A (fr)
IE (1) IE912815A1 (fr)
NZ (1) NZ239308A (fr)
PT (1) PT98612A (fr)
WO (1) WO1992002223A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117834A1 (fr) * 2004-05-27 2005-12-15 Janssen Pharmaceutica N.V. Dispersions solides d'un compose medicamenteux basique et d'un polymere renfermant des groupes acides
US10508373B2 (en) 2016-05-13 2019-12-17 Nike, Inc. Embroidered article

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332236C (fr) * 1985-10-11 1994-10-04 Lourens Wals N-oxydes d'–-–-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide
DE3906779A1 (de) * 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament

Also Published As

Publication number Publication date
FI930536A0 (fi) 1993-02-08
AU8440091A (en) 1992-03-02
AU661972B2 (en) 1995-08-17
IE912815A1 (en) 1992-02-12
CA2088273A1 (fr) 1992-02-10
FI930536A (fi) 1993-02-08
JPH06500104A (ja) 1994-01-06
NZ239308A (en) 1994-04-27
EP0542879A1 (fr) 1993-05-26
WO1992002223A1 (fr) 1992-02-20
PT98612A (pt) 1992-06-30

Similar Documents

Publication Publication Date Title
FI122717B (fi) Menetelmä valmistaa tramadolihydrokloridia hallitusti vapauttava valmiste
US5843480A (en) Controlled release diamorphine formulation
FI87424B (fi) Foerfarande foer framstaellning av fasta nifedipinpreparat, som biologiskt laett kan tillgodogoeras och som har en foerdroejd effekt.
DE69535426T2 (de) Schmelzextrudierte oral verabreichbare Opioidformulierungen
KR100365572B1 (ko) 서방성조성물및약학조성물의제조방법
JP2021038242A (ja) ルカパリブの高投与力価錠剤
KR100634253B1 (ko) 초강력 붕해제를 사용한 고속-용해 에파비렌즈 캡슐 또는정제 및 그의 제조 방법
US6558704B1 (en) Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredient
JP2002370983A (ja) 制御放出オキシコドン組成物
AT6542U1 (de) Tamsulosinpellets und verfahren zum herstellen derselben
CH705273B1 (de) Pharmazeutische Zusammensetzung – umfassend Hydromorphon und Naloxon.
WO2021238978A1 (fr) Composition pharmaceutique contenant un promédicament de nitroxoline, méthode de préparation et application de celle-ci
CN105935358A (zh) 一种沙库比曲缬沙坦缓释剂及其制备方法
CA2764172A1 (fr) Antagoniste du recepteur de la thrombine et comprime de clopidogrel a dose fixe
WO2014151547A1 (fr) Comprimés de sovaprévir
CA2088273C (fr) Procedes pour la formulation de composes a base de loperamide sous forme posologique orale solide
JP2022544167A (ja) ニトロキソリンを含む医薬組成物、ニトロキソリン経口固形錠剤、その調製方法、及びその使用
AU694475B2 (en) Pharmaceutical preparation
JPS625915A (ja) 塩酸ジルチアゼム徐放性製剤及びその製法
US20080194560A1 (en) Disintegration promoters in solid dose wet granulation formulations
CN115969801B (zh) 用于癌症的药物组合物及其制备方法
Perumal The Preparation and In-vitro Evaluation of Sustained Release Capsules of Rivastigmine Tartrate
CN106176664A (zh) 一种依维莫司胶囊及其制备方法
Babu FORMULATION AND EVALUATION AND STABILITY STUDIES OF BILAYER TABLETS OF METFORMIN AND LINAGLIPTIN
DE60224192T2 (de) Antihaemorrhagische, betain-enthaltende zusammensetzungen

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed